163 related articles for article (PubMed ID: 37066059)
21. Bacterial testing of platelets - has it prevented transfusion-transmitted bacterial infections in Australia?
Thyer J; Perkowska-Guse Z; Ismay SL; Keller AJ; Chan HT; Dennington PM; Bell B; Kotsiou G; Pink JM
Vox Sang; 2018 Jan; 113(1):13-20. PubMed ID: 28952159
[TBL] [Abstract][Full Text] [Related]
22. Benefit of transfusion-related acute lung injury risk-minimization measures--German haemovigilance data (2006-2010).
Funk MB; Guenay S; Lohmann A; Henseler O; Heiden M; Hanschmann KM; Keller-Stanislawski B
Vox Sang; 2012 May; 102(4):317-23. PubMed ID: 21967322
[TBL] [Abstract][Full Text] [Related]
23. Transition from fresh frozen plasma to solvent/detergent plasma in the Netherlands: comparing clinical use and transfusion reaction risks.
Saadah NH; Schipperus MR; Wiersum-Osselton JC; van Kraaij MG; Caram-Deelder C; Beckers EAM; Leyte A; Rondeel JMM; de Vooght KMK; Weerkamp F; Zwaginga JJ; van der Bom JG
Haematologica; 2020 Apr; 105(4):1158-1165. PubMed ID: 31273090
[TBL] [Abstract][Full Text] [Related]
24. Incidence of transfusion-related adverse reactions per patient reflects the potential risk of transfusion therapy in Japan.
Kato H; Uruma M; Okuyama Y; Fujita H; Handa M; Tomiyama Y; Shimodaira S; Kurata Y; Takamoto S
Am J Clin Pathol; 2013 Aug; 140(2):219-24. PubMed ID: 23897258
[TBL] [Abstract][Full Text] [Related]
25. Hemovigilance network in France: organization and analysis of immediate transfusion incident reports from 1994 to 1998.
Andreu G; Morel P; Forestier F; Debeir J; Rebibo D; Janvier G; Hervé P
Transfusion; 2002 Oct; 42(10):1356-64. PubMed ID: 12423521
[TBL] [Abstract][Full Text] [Related]
26. Transfusion-related adverse reactions: From institutional hemovigilance effort to National Hemovigilance program.
Vasudev R; Sawhney V; Dogra M; Raina TR
Asian J Transfus Sci; 2016; 10(1):31-6. PubMed ID: 27011667
[TBL] [Abstract][Full Text] [Related]
27. Safety Analysis of Extended Platelet Shelf-Life with Large-Volume Delayed Sampling on BACT/ALERT
Cheng A; Das A; Chaw K; Dennington PM; Styles CE; Gosbell IB
Microorganisms; 2023 Sep; 11(9):. PubMed ID: 37764190
[TBL] [Abstract][Full Text] [Related]
28. A Comparison of Transfusion-Related Adverse Reactions Among Apheresis Platelets, Whole Blood-Derived Platelets, and Platelets Subjected to Pathogen Reduction Technology as Reported to the National Healthcare Safety Network Hemovigilance Module.
Mowla SJ; Kracalik IT; Sapiano MRP; O'Hearn L; Andrzejewski C; Basavaraju SV
Transfus Med Rev; 2021 Apr; 35(2):78-84. PubMed ID: 33934903
[TBL] [Abstract][Full Text] [Related]
29. Bacterial contamination of platelets for transfusion: strategies for prevention.
Levy JH; Neal MD; Herman JH
Crit Care; 2018 Oct; 22(1):271. PubMed ID: 30367640
[TBL] [Abstract][Full Text] [Related]
30. Development and implementation of a hemovigilance program at a university veterinary teaching hospital.
Haines JM; Ngwenyama TR; Martin LG; Wardrop KJ
J Vet Emerg Crit Care (San Antonio); 2022 May; 32(3):315-321. PubMed ID: 35001463
[TBL] [Abstract][Full Text] [Related]
31. Hemovigilance monitoring of platelet septic reactions with effective bacterial protection systems.
Benjamin RJ; Braschler T; Weingand T; Corash LM
Transfusion; 2017 Dec; 57(12):2946-2957. PubMed ID: 28840603
[TBL] [Abstract][Full Text] [Related]
32. Screening of platelet concentrates for bacterial contamination: spectrum of bacteria detected, proportion of transfused units, and clinical follow-up.
Walther-Wenke G; Schrezenmeier H; Deitenbeck R; Geis G; Burkhart J; Höchsmann B; Sireis W; Schmidt M; Seifried E; Gebauer W; Liebscher UM; Weinauer F; Müller TH
Ann Hematol; 2010 Jan; 89(1):83-91. PubMed ID: 19484239
[TBL] [Abstract][Full Text] [Related]
33. Report on Notifications Pursuant to section sign21 German Transfusion Act for 2007.
Henseler O; Heiden M; Haschberger B; Hesse J; Seitz R
Transfus Med Hemother; 2010 Feb; 37(1):29-47. PubMed ID: 20737014
[TBL] [Abstract][Full Text] [Related]
34. Transfusion-related adverse reactions reported to the National Healthcare Safety Network Hemovigilance Module, United States, 2010 to 2012.
Harvey AR; Basavaraju SV; Chung KW; Kuehnert MJ
Transfusion; 2015 Apr; 55(4):709-18. PubMed ID: 25371300
[TBL] [Abstract][Full Text] [Related]
35. Benefits and harms of red blood cell transfusions in patients with septic shock in the intensive care unit.
Holst LB
Dan Med J; 2016 Feb; 63(2):. PubMed ID: 26836806
[TBL] [Abstract][Full Text] [Related]
36. Fatal transfusion-transmitted infection due to Citrobacter koseri.
Hauser L; Menasie S; Bonacorsi S; Raoult L; AitOubelli N; Belloy M; Avran D; Beyloune A; Simonet M; Billard-Pomares T; Pangon B; Bierling P
Transfusion; 2016 Jun; 56(6):1311-1313. PubMed ID: 27040329
[TBL] [Abstract][Full Text] [Related]
37. Erythropoietin plus iron versus control treatment including placebo or iron for preoperative anaemic adults undergoing non-cardiac surgery.
Kaufner L; von Heymann C; Henkelmann A; Pace NL; Weibel S; Kranke P; Meerpohl JJ; Gill R
Cochrane Database Syst Rev; 2020 Aug; 8(8):CD012451. PubMed ID: 32790892
[TBL] [Abstract][Full Text] [Related]
38. Hypersensitivity transfusion reactions to fresh frozen plasma: a retrospective analysis of the French hemovigilance network.
Tacquard C; Andreu G; Meyer N; Carlier M; Py JY; Drouet C; Bienvenu J; Mertes PM; Boudjedir K
Transfus Med Rev; 2022 Apr; 36(2):77-81. PubMed ID: 35501216
[TBL] [Abstract][Full Text] [Related]
39. Storage medium of platelet transfusions and the risk of transfusion-transmitted bacterial infections.
Kreuger AL; Middelburg RA; Kerkhoffs JH; Schipperus MR; Wiersum-Osselton JC; van der Bom JG
Transfusion; 2017 Mar; 57(3):657-660. PubMed ID: 28144957
[TBL] [Abstract][Full Text] [Related]
40. Patterns of Adverse Transfusion Reactions in a Tertiary Care Centre of North India: A Step Towards Hemovigilance.
Bassi R; Aggarwal S; Bhardwaj K; Thakur KK
Indian J Hematol Blood Transfus; 2017 Jun; 33(2):248-253. PubMed ID: 28596659
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
